Press Release Details

View all news

Study supports previously identified links between bovine meat and milk factor protein expression and inflammation as possible cause of colorectal cancer

02/22/2023

Bovine meat and milk factors (BMMFs)—initially identified by de Villiers et al. in 2014—represent a class of infectious agents in beef and cow's milk that have been linked to the development of cancer. New research published in Molecular Oncology suggests that monitoring the presence and rate of expression of a BMMF-encoded replication protein (Rep) in inflammatory sites of the tissues may help identify individuals at risk for developing colorectal cancer subsequently after decades-long latency periods./p>

The study compared the presence of Rep and specific immune cells in tissues from people with and without colorectal cancer. In addition to observing differences in Rep expression between these groups, the investigators identified the Rep in immune cells involved in inflammation in precancerous stages, supporting an early contribution of BMMF to colorectal cancer by inflammation-driven indirect carcinogenesis described by zur Hausen in 2001 and 2009.   

“With further studies, we aim to address whether the identification of BMMF-positive inflamed tissue can be used as an early risk marker for colorectal cancer. Therefore, first monitoring of Rep expression and inflammation in biopsies is important to better understand BMMF-specific induction of cancer and prognosis,” said corresponding author Timo Bund, PhD, of the German Cancer Research Centre. “The early identification of BMMF might offer new options for preventive and therapeutical intervention.”

URL upon publication: https://onlinelibrary.wiley.com/doi/10.1002/1878-0261.13390


Additional Information
NOTE: 
The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.

About the Journal
Molecular Oncology is a monthly online-only Open Access journal that highlights new discoveries, approaches, as well as technical developments, in basic, clinical and discovery-driven translational cancer research.

About Wiley
Wiley is one of the world’s largest publishers and a global leader in scientific research and career-connected education. Founded in 1807, Wiley enables discovery, powers education, and shapes workforces. Through its industry-leading content, digital platforms, and knowledge networks, the company delivers on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on FacebookTwitterLinkedIn and Instagram.

Multimedia Files:

View all news